【摘要】 对４８例Ｔ１Ｎ０Ｍ０乳腺癌患者进行激素受体与预后关系的分析，平均随诊时间为８．５年，全部病例行改良根治术，术后均未进行辅助治疗。雌激素受体或孕酮受体阳性组病例的无复发，生存率明显优于相应之阴性组病例。初步认为Ｔ１Ｎ０Ｍ０浸润性乳腺癌病例的雌激素及／或孕酮受体阴性者应进行术后化疗。更多还原

【Abstract】 Correlations between prognosis and hormone receptors were analyzed in 48 patients with T1N0M0 breast cancer at a mean follow-up duration of 8.5 years.All were treated by modified radical mastectomy without postoperative systemic adjuvant therapy.The relapse-free survival in patients with positive estrogen receptor or progesterone receptor was significantly better than those with negative estrogen receptor or progesterone receptor.It appeared to the authors that the postoperative adjuvant chemotherapy should be used in estrogen or progesterone receptor negative pstients with T1N0M0 invasive breast cancer.更多还原